This webinar will outline the key aspects of the new federal medicine price controls and impacts on patient access to innovative drugs, research and the life sciences sector in Quebec.

William Dempster and Johanne Chambers from 3Sixty Public Affairs will provide an overview of the reforms and the next steps that are being considered. The following speakers will then share their views on the issue:

  • Gail Ouellette, CEO of the Regroupement québécois des maladies orphelines (RQMO)
  • Dr. Angela Genge, Neurologist and Director, Clinical Research Unit Montreal Neurological Institute and Hospital
  • Jennifer Chan, Vice-President, Policy and External Affairs, Merck

We suggest